Ubiquitin-specific peptidases in lymphoma: a path to novel therapeutics
BackgroundUbiquitin-specific peptidases (USPs), also known as deubiquitinating enzymes (DUBs), play a crucial role in maintaining cellular homeostasis by selectively removing ubiquitin molecules from targeted proteins. This process affects protein stability, subcellular localization, and activity, t...
Saved in:
| Main Authors: | Maryam Samareh Salavatipour, Shirin Tavakoli, Aram Halimi, Shima Tavoosi, Amir-Hossein Baghsheikhi, Abdolkarim Talebi-Taheri, Mehdi Niloufari, Zahra Salehi, Javad Verdi, Soheila Rahgozar, Alireza Mosavi-Jarrahi, Mohammad Ahmadvand |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1356634/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A rare immune-related mesenteric and retroperitoneal serositis in a multirefractory Hodgkin lymphoma patient successfully treated with chylolymphostatic surgery
by: Matteo D'Addona, et al.
Published: (2023-10-01) -
Ubiquitin specific peptidase 11 knockdown slows Huntington’s disease progression via regulating mitochondrial dysfunction and neuronal damage depending on PTEN-mediated AKT pathway
by: Bai Gao, et al.
Published: (2025-01-01) -
Exploring the pediatric lymphoma landscape: State cancer institute experience
by: Shah SS, et al.
Published: (2025-03-01) -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
by: Claudio Agostinelli, et al.
Published: (2014-06-01) -
Value of accelerated hyperfraction dozes of radiation in primary radiation treatment for Hodgkin’s lymphoma
by: N. V. Ilyin, et al.
Published: (2022-11-01)